09:30 AM- 6:30PM
Febucan 40 is a xanthine oxidase inhibitor used for long-term management of hyperuricemia in patients with chronic gout. It reduces the production of uric acid, thereby lowering serum urate levels and preventing painful gout attacks. Febucan is a safer alternative to allopurinol in patients with hypersensitivity and has been FDA-approved for use since 2009.
Febuxostat 40 mg Tablets
Chronic management of Hyperuricemia in patients with Gout
Effective in patients who are intolerant or resistant to Allopurinol
Reduces serum uric acid (UA) levels significantly
The recommended dosage should be determined by a healthcare professional based on individual needs and medical history.1 tablet once daily with or without food
Not for use in asymptomatic hyperuricemia
Monitor liver function during prolonged use
May precipitate gout flares during the initial treatment phase (prophylactic NSAID or colchicine may be advised)
Use with caution in patients with cardiovascular disease or renal impairment
Regular uric acid monitoring recommended